Neogen Corporation Shares Outstanding (Cover Page)
Neogen Corporation (NEOG) had Shares Outstanding (Cover Page) of 218.06 million shares as of 2026-06-30, per its 10-K filed 2026-07-30.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-30
- 2026-06-30: Entity Common Stock, Shares Outstanding 218.06M shares.
- 2026-02-28: Entity Common Stock, Shares Outstanding 217.67M shares.
- 2025-11-30: Entity Common Stock, Shares Outstanding 217.53M shares.
- 2025-08-31: Entity Common Stock, Shares Outstanding 217.30M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-06-30 | 218.06M shares 10-K · filed 2026-07-30 |
| 2026-02-28 | 217.67M shares 10-Q · filed 2026-04-09 |
| 2025-11-30 | 217.53M shares 10-Q · filed 2026-01-08 |
| 2025-08-31 | 217.30M shares 10-Q · filed 2025-10-09 |
| 2025-06-30 | 217.21M shares 10-K · filed 2025-07-30 |
| 2025-02-28 | 217.04M shares 10-Q · filed 2025-04-09 |
| 2024-11-30 | 216.94M shares 10-Q · filed 2025-01-15 |
| 2024-08-31 | 216.70M shares 10-Q · filed 2024-10-10 |
| 2024-06-30 | 216.69M shares 10-K · filed 2024-07-30 |
| 2024-02-29 | 216.61M shares 10-Q · filed 2024-04-09 |
| 2023-11-30 | 216.52M shares 10-Q · filed 2024-01-09 |
| 2023-08-31 | 216.31M shares 10-Q · filed 2023-10-10 |
| 2023-06-30 | 216.31M shares 10-K · filed 2023-08-15 |
| 2023-02-28 | 216.22M shares 10-Q · filed 2023-04-04 |
| 2022-11-30 | 216.15M shares 10-Q · filed 2023-01-09 |
| 2022-08-31 | 107.84M shares 10-Q · filed 2022-09-30 |
| 2022-06-30 | 107.84M shares 10-K · filed 2022-07-27 |
| 2022-02-28 | 107.82M shares 10-Q · filed 2022-04-01 |
| 2021-11-30 | 107.77M shares 10-Q · filed 2021-12-30 |
| 2021-08-31 | 107.49M shares 10-Q · filed 2021-09-30 |
| 2021-06-30 | 107.48M shares 10-K · filed 2021-07-30 |
| 2021-02-28 | 53.51M shares 10-Q · filed 2021-03-31 |
| 2020-11-30 | 53.24M shares 10-Q · filed 2020-12-29 |
| 2020-08-31 | 53.04M shares 10-Q · filed 2020-09-30 |
| 2020-06-30 | 52.96M shares 10-K · filed 2020-07-30 |
| 2020-02-29 | 52.91M shares 10-Q · filed 2020-04-03 |
| 2019-11-30 | 52.71M shares 10-Q · filed 2019-12-27 |
| 2019-08-31 | 52.42M shares 10-Q · filed 2019-09-26 |
| 2019-06-30 | 52.28M shares 10-K · filed 2019-07-30 |
| 2019-02-28 | 52.12M shares 10-Q · filed 2019-03-29 |
| 2018-11-30 | 52.08M shares 10-Q · filed 2018-12-28 |
| 2018-08-31 | 52.00M shares 10-Q · filed 2018-10-05 |
| 2018-06-30 | 51.76M shares 10-K · filed 2018-07-27 |
| 2018-02-28 | 51.58M shares 10-Q · filed 2018-03-29 |
| 2017-12-31 | 51.52M shares 10-Q · filed 2018-01-05 |
| 2017-08-31 | 38.23M shares 10-Q · filed 2017-09-29 |
| 2017-06-30 | 38.21M shares 10-K · filed 2017-07-28 |
| 2017-02-28 | 38.12M shares 10-Q · filed 2017-03-31 |
| 2016-11-30 | 37.97M shares 10-Q · filed 2016-12-29 |
| 2016-08-31 | 37.71M shares 10-Q · filed 2016-09-30 |
| 2016-06-30 | 37.57M shares 10-K · filed 2016-07-29 |
| 2016-02-29 | 37.52M shares 10-Q · filed 2016-03-31 |
| 2015-11-30 | 37.44M shares 10-Q · filed 2016-01-08 |
| 2015-08-31 | 37.37M shares 10-Q · filed 2015-09-30 |
| 2015-06-30 | 37.13M shares 10-K · filed 2015-07-30 |
| 2015-02-28 | 37.04M shares 10-Q · filed 2015-04-01 |
| 2014-11-30 | 36.96M shares 10-Q · filed 2014-12-30 |
| 2014-08-31 | 36.93M shares 10-Q · filed 2014-09-30 |
| 2014-06-30 | 36.73M shares 10-K · filed 2014-07-30 |
| 2014-03-31 | 36.67M shares 10-Q · filed 2014-04-04 |
| 2013-12-01 | 36.60M shares 10-Q · filed 2014-01-09 |
| 2013-09-01 | 24.24M shares 10-Q · filed 2013-09-30 |
| 2013-06-30 | 24.07M shares 10-K · filed 2013-07-30 |
| 2013-03-01 | 23.92M shares 10-Q · filed 2013-03-28 |
| 2012-12-01 | 23.86M shares 10-Q · filed 2012-12-28 |
| 2012-09-01 | 23.80M shares 10-Q · filed 2012-09-28 |
| 2012-06-30 | 23.64M shares 10-K · filed 2012-07-30 |
| 2012-03-01 | 23.55M shares 10-Q · filed 2012-03-30 |
| 2011-12-01 | 23.53M shares 10-Q · filed 2011-12-30 |
| 2011-09-01 | 23.37M shares 10-Q · filed 2011-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |